MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Executive functions"

  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • 2017 International Congress

    Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale

    R. Fernandez-Bobadilla, S. Martinez-Horta, J. Marin-Lahoz, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To develop and validate an alternative form of the PD-CRS (PD-CRS/AF) with the objective of providing a reliable and fully equivalent method of reassessment…
  • 2017 International Congress

    Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson’s disease

    H. Sawada, S. Orimo, A. Inaba, M. Takahashi (Tokyo, Japan)

    Objective: The objective of this study is to investigate a relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT SPECT (dopamine transporter (DAT) SPECT) in…
  • 2017 International Congress

    Validation of Computerised Measures of Executive Functioning for use in Parkinson’s Disease Assessments.

    T. Dominey, C. Carroll, R. Noad, C. Newman, S. Hall (Plymouth, United Kingdom)

    Objective: i. To validate the use of a computerised finger tapping task as a screening measure for Executive Dysfunction (EF) in Parkinson’s Disease (PD), against…
  • 2017 International Congress

    Action Verbal Fluency is Related to the Functional Integrity of the Cognitive Cortico-Striatal Loop in Parkinson’s Disease

    N. Auclair-Ouellet, A. Hanganu, E. Mazerolle, J. Sarna, M. Kibreab, J. Cheetham, I. Kathol, A. Haffenden, B. Pike, O. Monchi (Calgary, AB, Canada)

    Objective: The objective of this study is to investigate the relationship between action verbal fluency (the capacity to name as many action words as possible…
  • 2017 International Congress

    IGF-1 levels are associated with CSF pathology and executive dysfunction in de novo Parkinson’s disease patients

    G. Dervenoulas, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To investigate whether serum insulin-like growth factor-1 (IGF-1) is associated with clinical-neuropsychiatric, imaging and CSF markers of PD pathology in patients with early, drug-naïve…
  • 2016 International Congress

    Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game

    A.C. Parr, B.C. Coe, G. Pari, D.P. Munoz (Kingston, ON, Canada)

    Objective: To characterize differences in choice patterns, and differentiate the effects of dopaminergic (DA) treatment on motor and cognitive function, during dynamic decision-making in Parkinson's…
  • 2016 International Congress

    Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

    B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

    Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…
  • 2016 International Congress

    The cognitive profile of idiopathic REM sleep behavior disorder

    L. Bernier-Lalonger, F. Escudier, P.A. Bourgouin, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

    Objective: The aim of this study was to examine the cognitive profile in a large cohort of patients with idiopathic REM sleep behavior disorder (iRBD).…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley